Alnylam Pharmaceuticals (ALNY) total debt

Total debt · fiscal 2025
$1.28B

Alnylam Pharmaceuticals (ALNY) carried total debt of $1.28B at the end of fiscal 2025 (December 31, 2025). That is 1.4% lower than the $1.30B of fiscal 2024. Figures as of 18 Nov 2026, 09:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$1.28B
Change on fiscal 2024
−1.4%
Highest on record
$1.32Bfiscal 2022
Lowest on record
$1.28Bfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Alnylam Pharmaceuticals total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $1.32B in fiscal 2022 and the lowest $1.28B in fiscal 2025.

Total debt was 1.6× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Alnylam Pharmaceuticals total debt, year by year

Alnylam Pharmaceuticals (ALNY) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$1.28B 1.4% down1.6×
2024$1.30B 0.7% down19.3×
2023$1.31B 1.1% down—
2022$1.32B——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Alnylam Pharmaceuticals and comparable companies
CompanyTotal debtFiscal year
Tenet Healthcare THC$13.17B2025
BioNTech BNTX€267.40M2025
Guardant Health GH$1.71B2025
Alnylam Pharmaceuticals ALNY$1.28B2025
Zimmer Biomet Holdings ZBH$7.52B2025
Medpace Holdings MEDP$113.64M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ALNY

Alnylam Pharmaceuticals, figure by figure

Alnylam Pharmaceuticals (ALNY) overview: price, valuation and scorecardAll health care companies by market value

Alnylam Pharmaceuticals total debt: questions and answers

How much debt does Alnylam Pharmaceuticals have?

Alnylam Pharmaceuticals (ALNY) carried total debt of $1.28B at the end of fiscal 2025 (December 31, 2025). That is 1.4% lower than the $1.30B of fiscal 2024.

What are the highest and lowest total debt figures on record for Alnylam Pharmaceuticals?

Across the 4 fiscal years on record (2022–2025), the highest was $1.32B in fiscal 2022 and the lowest $1.28B in fiscal 2025.

How does Alnylam Pharmaceuticals's debt compare with its equity?

Total debt was 1.6× shareholders' equity at the end of fiscal 2025.

How is Alnylam Pharmaceuticals's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Alnylam Pharmaceuticals it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alnylam Pharmaceuticals (ALNY) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/ALNY/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.